Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Biologic therapy. Toulouse III University and Larrey Hospital, Toulouse, France



Survival: 3.3 months
   
Toxicity Grade: 5
   
Treatments: Biologic therapy
   
Drugs:
Country: France
   
City/State/Province: Toulouse
   
Hospital: Toulouse III University and Larrey Hospital
   
Journal: Link
   
Date: 7/2013

Description:
Patients:
This study involved 38 metastatic melanoma patients with brain metastasis. The median patient age was 50 years and 68.4% were male.

Treatment:
Patients were treated with the biologic therapy agent called ipilimumab, which is a monoclonal antibody recognizing CTLA-4 that works to help the immune system attack tumor cells.

Toxicities:
There were eight treatment-related deaths due to intracranial hemorrhage and intracranial hypertension. Grade 3 fatigue and enterocolitis (inflammation of the digestive tract) were also reported.

Results:
The median overall survival was 3.3 months.

Support:
Study drug was provided by Bristol-Myers Squibb, makers of ipilimumab.

Correspondence: Dr. Nicolas Meyer; email: meyer.n@chu-toulouse.fr

E-mail to a Friend Email Physician More Information